Investment Information

With transparent disclosure of information and communication with markets,
we will grow along with shareholders.

HanAll to Present at Korea Bio Investment Conference 2021


Related Data

HanAll Biopharma (KRX: 009420.KS)​ will participate in the Korea Bio Investment Conference (KBIC) 2021 on Tuesday, December 7, 2021. Seung-Kook Park, PhD, President and Chief Executive Officer,​ will present at 4 p.m. KST. 

The presentation will also be available online via the KBIC's Youtube channel at​. 


The conference, taking place December 6-7, 2021, aims to introduce Korea-based biopharmaceutical companies and novel drug pipeline assets to investors, and will be held offline and streamed live online.